Land: Ierland
Taal: Engels
Bron: HPRA (Health Products Regulatory Authority)
Ivermectin
Virbac S.A.
QP54AA01
Ivermectin
20 mg/tablet
Chewable tablet
LR: Licensed Retailer as defined in national legislation
Horses
ivermectin
Endectoparasiticides
Authorised
2009-10-02
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Eraquell Tabs, 20 mg Chewable tablets for Horses 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 3 PHARMACEUTICAL FORM Chewable tablet. White, circular, biconcave tablet with brown spots. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of nematode and arthropod infestations, due to adult and immature roundworms and bots in horses: NEMATODES Large-strongyles: _Strongylus vulgaris_ (adult and arterial larvae) _Strongylus edentatus_ (adult and L4 tissue larval stages) _Strongylus equinus_ (adult and L4 larval stage) _Triodontophorus_ spp. (adult) Small-strongyles: Cyathostomum (adult and non-encysted mucosal larvae)_: Cylicocyclus_ spp._,_ _Cylicostephanus_ spp., _Gyalocephalus_ spp. Parascaris:_ Parascaris equorum_ (adult and larvae)_._ Oxyuris:_ Oxyuris equi_ (adult and larvae)_._ Trichostrongylus:_ Trichostrongylus axei_ (adult)_._ DIPTERAN INSECTS:_ Gasterophilus_ spp. (larvae). 4.3 CONTRAINDICATIONS Do not use in foals under 2 weeks of age. Do not use in horses known to be hypersensitive to the active ingredient or any of the other ingredients. Do not use in dogs or cats as severe adverse reactions may occur. Each chewable tablet of 3300 mg contains: ACTIVE SUBSTANCE Ivermectin 20 mg EXCIPIENTS For full list of excipients see section 6.1. H E A L T H P R O D U C T S R E G U L A T O R Y A U T H O R I T Y ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _2_ _/_ _0_ _8_ _/_ _2_ _0_ _1_ _4_ _C_ _R_ _ Lees het volledige document